2.85
price up icon7.14%   0.19
after-market Handel nachbörslich: 2.84 -0.01 -0.35%
loading

Annovis Bio Inc Aktie (ANVS) Neueste Nachrichten

pulisher
Jul 23, 2025

Is Annovis Bio Inc. a good long term investmentFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Annovis Bio Inc. stockFree Capital Allocation Plans - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Annovis Bio Inc. stock priceMassive portfolio appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Annovis Bio Inc. Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio stock rating cut to hold at D. Boral Capital - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio to Present Key Findings at Alzheimer’s Association International Conference - MSN

Jul 22, 2025
pulisher
Jul 18, 2025

What risks could impact Annovis Bio Inc. stock performanceCapital Growth Picks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Annovis Bio Inc. Advances Alzheimer’s Treatment with Buntanetap Study - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

Why Annovis Bio Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Annovis Bio Inc. stock price move sharplyFree Popular Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Annovis Bio Inc. stock performs during market volatilityCapital Growth Picks - newser.com

Jul 15, 2025
pulisher
Jul 12, 2025

Annovis Bio's Volatility Trap: Why Risky Bets and Biotech Headwinds Spell Caution for Investors - AInvest

Jul 12, 2025
pulisher
Jul 04, 2025

Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Parkinson's Disease Clinical and Non-Clinical Studies, Key - openPR.com

Jul 03, 2025
pulisher
Jun 30, 2025

Annovis Bio’s Alzheimer’s Study: A Potential Game-Changer for Investors? - TipRanks

Jun 30, 2025
pulisher
Jun 26, 2025

Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025 - citybuzz -

Jun 26, 2025
pulisher
Jun 25, 2025

Annovis Bio Plunges 10.13% on Analyst Price Target Cut - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Annovis Bio (ANVS) Stock Jumps Over 16% in Market Trading | ANVS Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Annovis Bio to Host Webcast on June 24, 2025, Featuring Updates on Phase 3 AD Trial and PD Program Development - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Annovis Bio Approves Board Elections and Auditor Appointment - TipRanks

Jun 23, 2025
pulisher
Jun 22, 2025

We Think Annovis Bio (NYSE:ANVS) Needs To Drive Business Growth Carefully - Yahoo Finance

Jun 22, 2025
pulisher
Jun 20, 2025

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Gains 18-Month NYSE Compliance Window - FinancialContent

Jun 20, 2025
pulisher
Jun 19, 2025

Annovis Bio Secures NYSE Approval to Regain Compliance with Listing Standards - MSN

Jun 19, 2025
pulisher
Jun 19, 2025

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance - The Manila Times

Jun 19, 2025
pulisher
Jun 14, 2025

10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Has Optimistic View of Annovis Bio Q2 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Q1 Earnings Forecast for Annovis Bio Issued By HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Annovis Bio (NYSE:ANVS) Price Target Cut to $12.00 by Analysts at HC Wainwright - Defense World

Jun 10, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):